Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.11% | 63.13 | 1.0% | $460.49m | |
| AMGN | Amgen, Inc. | 0.18% | 240.94 | 1.3% | $449.35m | |
| BIIB | Biogen, Inc. | 0.01% | 286.16 | 1.4% | $389.08m | |
| ILMN | Illumina, Inc. | -0.38% | 324.71 | 3.5% | $319.29m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.03% | 233.08 | 1.9% | $297.00m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.56% | 383.42 | 2.6% | $228.58m | |
| EXAS | EXACT Sciences Corp. | -0.47% | 89.36 | 24.0% | $203.43m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.28% | 113.95 | 2.0% | $196.36m | |
| ITCI | Intra-Cellular Therapies, Inc. | 1.20% | 26.95 | 9.0% | $177.91m | |
| INCY | Incyte Corp. | -0.19% | 80.47 | 2.5% | $149.09m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.34% | 128.55 | 14.6% | $143.19m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | -0.49% | 56.83 | 11.4% | $132.82m | |
| SGEN | Seattle Genetics, Inc. | 1.12% | 108.86 | 6.1% | $126.83m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.64% | 88.56 | 4.3% | $108.58m | |
| A | Agilent Technologies, Inc. | 0.68% | 90.07 | 1.6% | $106.43m |
Company Profile
Blueprint Medicines Corp. is a precision therapy company, which focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.